CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas
Article in Clinical and Experimental Medicine (September 2023)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas
Preprint in Research Square (March 2023)
Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer
Article in Journal of Biosciences (April 2022)